Human CCR7 full length protein-synthetic nanodisc FLP100060
Specifications
| 10µg / 50µg / 100µg |
Alternative names:
BLR2; CC-CKR-7; CCR-7; CD197; CDw197; CMKBR7; EBI1
Description:
Human CCR7 full length protein-synthetic nanodisc
Background:
The protein is a member of the G protein-coupled receptor family. This receptor was identified as a gene induced by the Epstein-Barr virus (EBV), and is thought to be a mediator of EBV effects on B lymphocytes. This receptor is expressed in various lymphoid tissues and activates B and T lymphocytes. It has been shown to control the migration of memory T cells to inflamed tissues, as well as stimulate dendritic cell maturation. The chemokine (C-C motif) ligand 19 (CCL19/ECL) has been reported to be a specific ligand of this receptor. Signals mediated by this receptor regulate T cell homeostasis in lymph nodes, and may also function in the activation and polarization of T cells, and in chronic inflammation pathogenesis.
Protein families:
Druggable Genome, GPCR, Transmembrane
Protein pathways:
Chemokine signaling pathway, Cytokine-cytokine receptor interaction
Expression host:
HEK293
Target:
CCR7
Molecular weight:
The human full length CCR7 protein has a MW of 42.9 kDa
Formulation / Reconstitution:
Lyophilized from nanodisc solubilization buffer (20 mM Tris-HCl, 150 mM NaCl, pH 8.0). Normally 5% - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Usage:
Research use only
More info:
Email info@sobekbio.com
Orders:
Email orders@sobekbio.com
